Supporting Complex Cell & Gene Therapy Trials in Israel
Cell and Gene Therapy (CGT) is transforming the treatment landscape for patients with serious and life-threatening disease. Unlike traditional therapies, these highly personalised treatments often involve living cells and biological materials that must be handled under exceptionally strict conditions. Every step of the supply chain, from manufacturing and storage to transportation and patient administration, plays a critical role in ensuring treatment integrity and, ultimately, patient outcomes.
As CGT clinical trials expand globally, sponsors face increasing operational challenges in managing complex logistics, specialised equipment requirements, and local regulatory considerations. Success depends not only on maintaining the cryogenic supply chain but also on ensuring that clinical sites have immediate access to the ancillary materials and equipment needed to treat patients safely and on schedule.
This was the challenge faced by a global biotechnology company conducting an advanced Cell & Gene Therapy study in Israel.
Challenge
The sponsor was running a highly complex LN2-based Cell & Gene Therapy study in Israel requiring not only cryogenic storage and distribution, but also rapid access to specialised ancillary equipment and locally sourced products essential for patient treatment.
In Cell & Gene Therapy studies, patient treatment windows are often tightly defined, leaving little room for delays or supply disruptions. The sponsor needed a trusted local partner capable of coordinating multiple moving parts while ensuring every component was available exactly when required.
The challenge included:
- Procurement of highly specialised medical equipment and consumables within Israel;
- Ensuring compatibility of all ancillary materials with clinical protocols;
- Coordinating multiple suppliers while maintaining strict timelines;
- Supporting LN2 storage and handling requirements for temperature-sensitive investigational products;
- Reducing operational burden for the sponsor by providing a single local point of contact.
Oximio’s Solution
Oximio acted as a local partner in Israel, providing an end-to-end procurement and logistics solution to support the study.
Working as an extension of the sponsor’s team, we coordinated the sourcing, qualification, and delivery of critical materials while ensuring alignment with patient treatment programs and protocol requirements.
Our support included:
- Local procurement and supply of specialised equipment and ancillary materials
- Vendor qualification and supplier management
- Coordination of delivery timelines aligned with patient treatment schedules
- Integration of locally sourced products into the clinical supply chain
- Support for LN2 storage and handling activities
Examples of locally procured materials included:
- Cryogenic water bath for LN2 product thawing
- Lymphodepletion supportive medications
- Ultra-low temperature freezer
- Laboratory water bath with solid lid
- Syringe Pump SYS-3010
- Central Venous Catheterization Kits
- Original Perfusor N infusion lines
By managing procurement locally and coordinating multiple suppliers through a single operational framework, we helped ensure that critical equipment and consumables were available when and where they were needed.
Outcome
The study was supported through a streamlined local solution that reduced complexity and helped maintain operational continuity throughout the trial.
- Successful support of Cell & Gene Therapy operations in Israel
- Timely availability of all critical equipment and ancillary materials
- Reduced complexity for the sponsor through a single local service provider
- Improved study continuity and patient readiness
- Demonstrated Oximio’s capability to support highly specialised LN2 and Cell & Gene Therapy trials beyond traditional depot services
Key Value Delivered
As Cell & Gene Therapy trials continue to expand into new markets, sponsors increasingly require partners who can do more than simply store and distribute investigational products. A successful outcome depends on finding the right partner who can bridge global clinical supply strategies with local execution.
Oximio goes beyond traditional depot services by acting as an integrated local partner, enabling sponsors to navigate complex Cell & Gene Therapy requirements through procurement, logistics, and operational expertise. By combining cryogenic supply chain capabilities with local market knowledge and supplier management, we were able to help the sponsor maintain focus on what matters most – delivering innovative therapies to their patients.
Comparator Sourcing for Clinical Trials
With a global footprint, Oximo’s comparator sourcing extends worldwide. Utilising our expert marketing knowledge and experience, we secure the best cost and quickest lead times to provide the highest quality medicinal and ancillary products.
Visit our website to view our comparator sourcing medicinal product list or contact us to discuss your requirements. We’d be delighted to assist you with your research.
Eliminating Risk in Global Distribution Through Proactive Supply Chain Control
When it comes to clinical trials for temperature sensitive biologics, the margin for error doesn’t exist. Even minor deviations can compromise product integrity, disrupt dosing schedules, and introduce regulatory and financial risk.
Recently, our Canadian team was put to the test, proving that compliance isn’t just about following rules, it’s about engineering reliability.
The Challenge
A pharmaceutical innovator developed a sensitive novel biologic requiring a non-negotiable, narrow temperature range. The mission was complex: transport the investigational product from the manufacturing floor to multiple clinical sites spanning several continents.
The risks were significant:
- Extreme Ambient Variables: Moving across different climate zones and hemispheres.
- Product Fragility: The biologic was highly susceptible to degradation if exposed to even brief thermal excursions.
The Solution
Rather than relying on standard logistics processes, Oximio designed a proactive control strategy focused on prevention, visibility, and rapid response. Aligned with Principle 12 of the Good Clinical Practices (GCP) requirements for investigational product handling, the approach extended beyond compliance to actively eliminate risk::
- Advanced Thermal Packaging: Utilised leading insulation materials tailored for long-haul durability and high-performance thermal resistance.
- Active Monitoring: We integrated temperature monitoring devices that provided continuous real-time tracking of the shipment.
- Proactive Intervention: The system was programmed with instant alerts, allowing our logistics experts to identify any potential issues before they arose.
- GMP-Aligned Handling: Every step of the process was executed in strict accordance with Good Manufacturing Practices (GMP) and the specific approved trial protocol.
The Outcome
By treating Principle 12 as a blueprint for innovation, the Canadian team achieved a fully controlled and interruption-free distribution program:
- 100% Stability: Every unit arrived at its destination in optimal condition, with zero temperature excursions recorded.
- Regulatory Peace of Mind: The comprehensive data logs provided a “gold standard” audit trail for the trial sponsors.
- Trial Success: With the product’s efficacy preserved, the trial proceeded on schedule, ensuring the integrity of the clinical data.
Why It Matters
In global biologic trials, success is not defined by reacting to issues, it is defined by preventing them.
This case demonstrates how a proactive, control-based supply chain strategy can eliminate risk and protect both patients and clinical outcomes. The approach is grounded in regulatory standards and designed for real-world complexity.
Partner With Oximio’s Supply Chain Solutions for Your Next Clinical Trial
Whether you are navigating complex biologics or global distribution hurdles, our expert team provides the quality, reliability, and innovation required to protect your trial’s integrity.
Visit our website for further information on the supply chain solutions for clinical trials provided by Oximio, Canada or explore our global network to find your nearest Oximio depot.
Supporting a Small Biotech to Deliver a Critical Phase III Clinical Trial in Canada
Our Canadian team was recently delighted to support a small biotech company developing innovative vaccine therapies. When this client faced the risk of delays in a pivotal Phase III trial, our team delivered a zero-excursion, fully compliant supply chain solution – ensuring uninterrupted patient enrolment and execution.
The client, with a lean clinical operations team of just 12 people, was facing several key challenges:
- Limited attention and prioritisation from larger vendors
- Complex handling requirements for temperature-sensitive vaccines
- The need for specialized labelling, storage, and Importer of Record (IoR) services
- Pressure to meet highly competitive enrolment timelines for a pivotal Phase III trial
The Challenge
This US-headquartered biotech, with operations in Canada, was preparing for a Phase III clinical trial critical to its commercial success. However, as a smaller organisation, they had consistently struggled to receive the level of attention and service quality expected from larger suppliers.
Despite the high standards required for Phase III studies, the client found that many large vendors deprioritised smaller sponsors, impacting responsiveness, flexibility, and overall execution. Recognising the importance of getting this trial right, they made a strategic decision to partner with a specialist provider better aligned to their size and needs.
Internally, the company chose to focus its resources on core competencies across study design, clinical science, and trial execution, while outsourcing key operational components such as packaging, distribution, and logistics.
Through a trusted referral, our Canadian team was selected to support the study. The client required not just operational execution, but a partner capable of acting as an extension of their team—providing proactive guidance and rapid responsiveness.
Our Solution
We approached this partnership with a clear objective: to deliver the same level of attention, quality, and responsiveness that we provide to all our global clients regardless of size.
From study start-up, we worked closely with the sponsor to design a flexible, end-to-end logistics strategy tailored to their specific requirements. This included:
- Temperature-controlled logistics: Managing frozen storage and handling of sensitive vaccine products with strict adherence to protocol requirements
- Specialist courier selection: Leading the identification and qualification of a logistics partner capable of maintaining product integrity throughout transit
- Labelling and storage services: Providing fully compliant labelling, as well as refrigerated and frozen storage solutions
- Importer of Record (IoR) services: Assuming legal responsibility for shipments, ensuring all regulatory documentation was accurate and complete
Given the regulatory complexity, we ensured full compliance with both Health Canada and U.S. FDA requirements, including the management of necessary documentation such as No Objection Letters and import permits.
To support the client’s competitive enrolment targets, we implemented a proactive, demand driven scheduling approach, ensuring sites received product exactly when needed, without delays or shortages.
Throughout the study, we maintained a high-touch communication model, including weekly calls during start-up and regular distribution updates, ensuring full transparency and eliminating uncertainty around product status.
The Outcome
Our tailored, proactive approach enabled the successful execution of a highly complex clinical trial:
- 103 shipments delivered across two protocols within 12 months
- Zero temperature excursions, ensuring full product usability upon arrival
- No delays or holds due to regulatory or documentation issues
- On-time support of competitive patient enrolment rates
The client particularly valued the responsiveness and accessibility of our team, noting that challenges were quickly identified and resolved, with clear corrective actions implemented.
As the study progresses toward closeout, timelines remain on track, and the partnership continues to strengthen.
Conclusion
This project demonstrated the value of a collaborative, high-touch approach to clinical trial logistics. By combining specialist expertise, proactive communication, and a commitment to treating every client as a priority, we enabled this small biotech to successfully deliver a critical Phase III trial.
The relationship established through this study is now extending into future programmes, reflecting the trust built and the consistent quality delivered.
Oximio’s Clinical Trial Supply Chain Solutions in Canada
If you are planning your next clinical trial in Canada or North America, take a moment to discover our comprehensive range of supply chain solutions across the region, or contact us to find out how we can support your research. We’d be happy to help.
Quick, Compliant Turnaround of Vital Temperature Sensitive Medicinal Products in Kenya
When it comes to delivering essential medication, time and precision are critical. Delays in the supply chain can directly impact patient outcomes, making speed, accuracy, and compliance non-negotiable. Across our global network, our teams are trusted to handle complex, time-sensitive pharmaceutical operations while maintaining the highest quality standards. This was highlighted by a recent request for our Oximio team in Kenya which showcased streamlined and flawless execution in action.
The Challenge
The Kenyan team received a significant inbound, bulk shipment of Investigational Medicinal Products (IMPs) as part of an urgent CRO order. The shipment required rapid turnaround while ensuring strict adherence to temperature control, quality, and regulatory requirements.
The scope of work included:
- Full unloading of the inbound shipment from the delivery truck
- Detailed checking and verification
- Careful unpacking and preparation readiness for onward redistribution
- Continuous handling within a 2–8°C temperature-controlled environment
Given the volume and critical nature of the products, the task demanded close coordination, attention to detail, and careful processing.
The Solution
Our Kenyan team mobilised quickly, working with focus and precision to successfully complete the entire process in under two working days. All activities were carried out within the designated temperature-controlled specification, ensuring full compliance with quality and regulatory standards throughout the operation.
Despite the demanding nature of the shipment, the team maintained accuracy at every step, from verification through to readiness for onward distribution, demonstrating strong operational discipline and teamwork.
The Outcome
- Large, bulk shipments of IMPs processed efficiently and compliantly
- End-to-end handling completed in under two working days
- 100% adherence to 2–8°C temperature requirements
- IMPs ready for onward distribution
Key Takeaway
This operation highlights the strength of our Kenya team and our broader global capabilities: the ability to move vital medicinal products quickly, safely, and reliably, even under demanding conditions. Their dedication, coordination, and commitment to excellence ensured that critical medications ready for their continued journey without delay.
Clinical Trial Supply Chain Solutions in Africa
With depots in Kenya and South Africa, and a qualified and experienced team on the ground, Oximio can provide tailor-made solutions to support even the most complex or demanding clinical trial requirements.
For further information on our African and global capabilities, visit our website or contact us to discuss your supply chain needs.
Oximio Kenya’s Rapid Response to Marburg Virus Outbreak in Ethiopia
When infectious disease outbreaks emerge, speed, precision, and trust in the supply chain can make a life-saving difference. In late 2025, as Ethiopia faced its first-ever outbreak of Marburg virus disease (MVD), our teams were called upon to act quickly. What followed was a powerful example of how local expertise, global capabilities, and rapid execution can support clinical and public health responses in the most challenging circumstances.
Background: Understanding the Marburg Virus
Marburg virus disease (MVD), formerly known as Marburg haemorrhagic fever, is a rare but severe illness with a high fatality rate. On average, MVD claims around 50% of those infected, with historical outbreaks showing fatality rates ranging from 24% to as high as 88%.
The virus spreads rapidly and can overwhelm healthcare systems if not controlled early. While there are currently no approved vaccines or antiviral treatments, early supportive care, such as rehydration and symptom management, has been shown to significantly improve survival. Community engagement, rapid diagnostics, and well-coordinated clinical response efforts are all essential to containing outbreaks and limiting their impact.
On 14 November 2025, the Ethiopia Ministry of Health officially reported the country’s first Marburg outbreak, triggering an urgent international response.
The Challenge: A Time-Critical Request
In the immediate aftermath of the announcement, Oximio was contacted by the African Disease Division of a large Contract Research Organisation (CRO). They required an urgent delivery of ancillary supplies to support outbreak control efforts. Time was critical. Any delay could hinder frontline response activities during a fast-moving public health emergency.
The responsibility fell to our Kenya-based team, who were tasked with sourcing, preparing, and mobilising the required supplies in the shortest possible timeframe, all whilst under intense pressure and with no margin for error.
Our Response: Agility in Action
Despite the urgency, our teams rose to the challenge. Through seamless coordination, decisive action, and deep regional expertise, the order was completed in under 48 hours and made ready for shipment.
In an outbreak response scenario, this speed is not just impressive, it’s essential. The successful execution demonstrated our ability to operate with agility while maintaining the high standards required in clinical trial and public health supply chains.
The client later shared their sincere appreciation for the exceptional responsiveness and service delivered, reinforcing the trust placed in our teams when it matters most.
Conclusion: Trusted Support When It Matters Most
This case highlights our commitment to supporting clinical trials and public health initiatives across Africa, even in the most demanding circumstances. From rapid mobilisation to reliable execution, our teams continue to demonstrate collaboration, resilience, and dedication to our mission.
To find out how our African-based operations can support your clinical trial and outbreak response needs, please visit our website or contact us to discuss your requirements. We’d be happy to help.
Supporting Customer Growth Across Sub-Saharan Africa
Faced with a growing client base and increased demand for their high-end medical devices and ancillaries, a South African surgical ophthalmic distributor, reached out to Oximio for support in satisfying their own customers’ needs.
The Challenge
Supporting eye care services across the region, they faced several operational and regulatory challenges as they worked to expand their presence, particularly in Kenya and surrounding countries. These included:
- Cross-border logistics complexities
- The need to register certain medical devices in Kenya
- A requirement for localised support in managing imports, warehousing, and last-mile distribution
To meet these challenges, it was essential to secure the help of a trusted logistics and regulatory partner capable of navigating complex cross-border issues, ensuring compliance with local regulations, and facilitating efficient distribution across multiple markets. They reached out to Oximio to explore a strategic partnership that could streamline their operations, support regulatory compliance, and provide scalable logistical solutions. This vital collaboration would serve as a key pillar in their growth strategy across sub-Saharan Africa.
Why Partner with Oximio?
Oximio’s comprehensive suite of services made it the ideal partner for our customer. Our strategic presence in East Africa, coupled with our deep regulatory knowledge and proven expertise in healthcare logistics, positioned us as the perfect solution provider for their needs. Our customer was impressed with the professionalism of Oximio’s operational and project management teams and our ability to solve complex logistical and regulatory challenges to global standards.
The Solution
Oximio provided a suite of tailored services that directly addressed our customer’s unique challenges. These included:
- Local Technical Representative (LTR) Services:
Acting as the company’s regulatory representative in Kenya, Oximio took charge of managing the product registration process, ensuring full compliance with the Kenyan Pharmacy and Poisons Board. This allowed our customer to focus on expanding their product offerings while we handled the intricacies of regulatory approval. - Bonded Warehouse Services:
We provided bonded warehousing, allowing our customer to import products in bulk without incurring taxes upfront. Taxes are only paid when products are released for local use, which improved cash flow and operational efficiency. This also supported the customer’s goal of using Kenya as a regional distribution hub for the wider Sub-Saharan market. - Cross-Border Transit Logistics:
Oximio offered streamlined cross-border logistics, managing shipments directly from the customer’s depot in South Africa to their customers in Kenya. We handled all aspects of import documentation, transportation, and customs clearance, ensuring timely delivery without costly delays. - Scalable Storage Solutions:
As the demand for products grew, we were able to provide scalable storage options that allowed our customer to store large quantities of ophthalmic devices efficiently. This flexibility enabled them to break bulk and distribute products quickly to various clients across Kenya. - Importer of Record (IOR) Services:
Oximio took responsibility for all import documentation, ensuring seamless customs clearance and compliance with all import regulations. This allowed the customer to operate with minimal friction and focus on their core business.
The Outcome: Growth & Operational Efficiency
The strategic partnership with Oximio has led to tangible benefits for our customer:
- Regulatory Compliance in Kenya: Our expertise in navigating the regulatory landscape helped the company achieve a solid foothold in Kenya, enabling them to expand their product offerings with confidence.
- Streamlined Cross-Border Distribution: Efficient logistics solutions significantly reduced delays and costs associated with cross-border transportation and customs clearance.
- Cost Savings and Efficiency: By leveraging Oximio’s bonded warehouse services and import management, the company was able to minimise upfront costs and reduce customs delays, improving overall operational efficiency.
- Regional Expansion: The customer is now well-positioned to grow its presence across East and sub-Saharan Africa, enhancing brand visibility and strengthening relationships with clients in multiple markets.
This partnership is a clear demonstration of Oximio’s commitment to providing scalable, tailored and compliant logistics solutions that support the growth and success of healthcare companies across the continent. Through our expertise in logistics, regulatory compliance, and warehousing, we have helped our customer not only meet their immediate operational needs but also set the stage for long-term success in the region.
Oximio in Africa
To find out how our end-to-end supply chain solutions can support your clinical trials within Africa, explore our full range of clinical trial logistic services within the region.
With a network of wholly owned and partner depots, we are able to further support your clinical research from Africa – and into Europe, North America, LATAM, MENA and Asia.
Why not contact us today to discuss your requirements. We’d be delighted to partner with you on your next clinical trial.
accum volupta nobis min porae estinve llaborehente consedit.
Supporting A Young Patient with Critical Needs in Ukraine
Introduction
At OXIMIO, our core values of care and commitment extend far beyond business – they define who we are and our mission to serve and support communities worldwide. As a leading supply chain solutions provider for clinical trials, we are dedicated to facilitating patient access to life-saving treatments. In this case study we illustrate how our team in Ukraine responded to a unique and urgent request for support, ensuring the timely importation and delivery of essential medical kits to a child suffering from spinal muscular atrophy (SMA).
Requirement
The situation began when a patient support organisation reached out to OXIMIO for assistance. The organisation was working with a child in Ukraine who had been enrolled in a 2017 multi-centre study led by a European multinational healthcare company. This study had been set up to investigate a treatment for infants with SMA Type 1, a rare and debilitating condition.
While the clinical trial had concluded, the pharmaceutical company made a five-year commitment to continue providing the child with vital medical supplies. The challenge, however, arose when the patient support organisation encountered significant logistical and regulatory obstacles in importing and delivering these life-sustaining kits. The absence of a registered post-trial programme in Ukraine complicated the process, leaving the organisation in need of a trusted partner who could navigate these complexities.
Solution
OXIMIO was uniquely positioned to address this challenge, thanks to our extensive expertise and international presence in the supply chain sector for clinical trials. Our teams in Ukraine, Hungary, and CARE collaborated closely to develop a tailored solution that identified and leveraged alternative, compliant legal pathways to address regulatory complexities and ensure the timely delivery of the required medical kits.
This success reflects the strong coordination and shared commitment of our cross-country and cross-functional teams, who worked together to design and implement a unified strategy that addressed both logistical and regulatory complexities. It included:
- Coordinating with local authorities to understand the specific regulatory requirements.
- Managing international logistics across multiple countries to facilitate the safe and efficient transport of the medical kits.
- Providing updates and continuous communication with the patient support organisation to ensure transparency and minimise any delays.
This collaborative approach allowed us to address the logistical and regulatory challenges swiftly and successfully, ensuring that the child received the necessary medical kits without disruption.
Outcome and Impact
The successful delivery of the medical kits was a testament to the power of cross-border collaboration and our ability to respond swiftly to urgent, life-changing needs. By overcoming logistical challenges and ensuring the timely importation of essential supplies, we not only supported the continuation of the child’s treatment but also reinforced our commitment to being more than just a service provider.
This initiative demonstrated our dedication to making a tangible impact on patients’ lives, especially in critical situations where time is of the essence.
Conclusion
At OXIMIO, our core values of care and commitment guide every decision we make, and this case study exemplifies our dedication to supporting patients in their most vulnerable moments. We extend our heartfelt gratitude to the patient support organisation for their trust and collaboration. Moreover, we commend our teams for their dedication, expertise, and seamless coordination across borders.
Supply Chain Solutions for Clinical Trials
To find out how we can support your clinical trial, why not explore our supply chain solutions across logistics, patient care and comparator sourcing.
Bringing Vital Hemostatic Agents from US to Ukraine
Introduction
Hemostatic agents are critical in military settings, particularly in combat situations where severe bleeding occurs. These products are vital in the first minutes following an injury and are designed to quickly stop bleeding and prevent hemorrhagic shock, saving lives on the battlefield.
Requirement
Oximio, Ukraine, was recently contacted by a U.S. based hemostatic agent manufacturer who sought to support Ukraine’s military efforts in the on-going war with Russia by providing essential donations. They needed a reliable logistics partner to facilitate the importation and distribution of these essential supplies to medical centres supporting the country’s frontline.
Solution
With over 20 years extensive experience in international logistics, Oximio leveraged its strong network in Ukraine, including close connections with the Ministry of Health, to create a taskforce to manage the importation, customs clearance, and transportation of approximately 10 shipments of critical supplies.
Our thorough understanding of both global and local logistics, particularly in war-torn times, and regulatory requirements was vital to ensure that the products were delivered without delay and met and complied with quality standards.
Outcome
In addition to the successful delivery of the shipments, the U.S. company won a tender to provide large-scale assistance to Ukraine, further expanding their service contribution. There was also a subsequent request for the collection of data on the usage of these products.
Our efficient and flexible approach enabled the U.S. manufacturer to deliver crucial hemostatic agents to frontline zones in Ukraine, significantly contributing to military medical efforts. The timely and successful shipments directly supported the company’s large-scale engagement in Ukraine. Furthermore, the comprehensive data collection on product usage facilitated ongoing research, adding value to the medical community’s understanding of hemostatic products.
Conclusion
This project highlights the importance of a reliable, client-oriented logistics partner in ensuring the successful delivery of mission-critical supplies in high-stakes environments. Through our expertise and customised solutions, we not only assisted Ukraine in its medical response but also contributed to valuable scientific research, reinforcing our commitment to supporting global healthcare efforts.
Oximio’s Clinical Trial Solutions in Ukraine
Explore our comprehensive supply chain solutions supporting clinical studies in Ukraine, or contact us directly for further information. We’d be delighted to discuss your requirements.
Oximio Ukraine: Leading the Way in Clinical Trial Supply Chain Solutions During the War
Despite the ongoing war in Ukraine, the need for clinical trials remains critical. In 2024 alone, from January to October, 46 new studies received approval, with 40 of them being multinational collaborations and six local initiatives. This resilience highlights the essential role of clinical research in advancing healthcare.
Established in 2004, Oximio, Ukraine has a profound understanding of patient care and the complexities of the clinical trial landscape. We are proud to have positioned ourselves as a leader in the industry, currently supporting over 62% of the new studies approved this year. Our success is rooted in our commitment to continuity and adaptability, especially in these challenging times.
Navigating Challenges with Robust Planning
Thanks to comprehensive business continuity plans that ensure uninterrupted operations and the safety of our personnel we have continued to provide agile logistics solutions for sponsors and CROs within the country. Key strategies include:
Availability and Security of Warehouse Staff
The safety and availability of our warehouse personnel are paramount. We have constructed an anti-attack shelter adjacent to our warehouse to protect our team and ensure they can carry out their daily tasks without disruption.
Reliable Power Supplies
Our facilities are equipped with two high-power diesel generators that maintain electricity in all temperature-controlled areas, including refrigerators and freezers. Regular maintenance and testing have ensured these systems function without issues, and we maintain an adequate fuel supply for uninterrupted operations.
Backup Heating Solutions
To safeguard the integrity of our temperature-sensitive materials, our depots are fitted with alternative heating solutions that operate independently of gas supplies. The ventilation system at our Krushynka depot has been modernized, and we have implemented an additional independent electric heating system connected to our generators. Meanwhile, our Brody depot features a solid fuel heating system, ensuring we can maintain optimal conditions year-round.
Distribution Availability
We have secured ongoing fuel supplies through contracts with leading gas stations and have established a three-week fuel storage supporting the uninterupted completion of all deliveries.
Robust Communication Systems
To ensure seamless communication and coordination, our action plan includes provisions for internet connectivity disruptions. We have established connections with two internet providers, alongside backup satellite and fiber optic systems, ensuring we stay connected with our clients and partners globally.
A Commitment to Patient Care
At Oximio, our core values revolve around the safety of our staff and the delivery of patient care. We understand that the stakes are high in clinical trials, and our commitment to excellence drives us to adapt and innovate continuously. The ongoing conflict in Ukraine has posed many challenges, but it has also reinforced our resolve to support vital clinical research initiatives.
As we look to the future, we remain dedicated to providing unparalleled supply chain solutions for clinical trials, ensuring that the essential work of advancing healthcare continues, even in the face of adversity. Our international team, combined with our robust operational strategies, position us as a trusted partner in the global clinical research community.
Together, we are navigating these challenging times with resilience and purpose, ensuring that patient care remains at the heart of everything we do.
Clinical Trial Supply Chain Solutions Ukraine
If you are seeking support for your clinical trial within Ukraine, view our comprehensive supply chain solutions or contact us. Offering agile and tailor-made solutions, we would welcome the opportunity to discuss your unique requirements.
Case Study: Efficient Import, Storage, and Distribution of Diagnostic TB Kits for Research Study in Sub-Saharan Africa
Background & Challenge
Oximio recently received a call from a team of researchers in sub-Saharan Africa in urgent need of help for the import, storage, and distribution of diagnostic kits and medical devices to multiple study sites across the region. They were undertaking a study on tuberculosis (TB) which aimed to improve patient diagnostics in underserved areas. The trial involved sensitive diagnostic kits with strict temperature control ranging from frozen to ultra-low temperatures.
The challenge was to ensure that the diagnostic kits arrived at four study sites in Tanzania and Uganda in a timely manner, within the required temperature ranges, and ready for immediate use in patient diagnostics. Additionally, managing the customs processes and logistics across multiple countries, while maintaining regulatory compliance and minimising delays, was critical to the study’s success.
Solution: Streamlined Logistics and Temperature Control
To meet the demanding logistics requirements Oximio devised an efficient strategy that addressed both the regulatory complexities and the need for strict temperature control during storage and transit.
- Importation and Customs Clearance: Oximio coordinated the Import of Record (IoR) and cleared three bulk shipments through Jomo Kenyatta International Airport (NBO) in Nairobi, Kenya utilising our customs bonded warehouse near Nairobi to receive and store the shipments securely. The strategic location of our warehouse meant it was well placed to support the subsequent distribution to the study sites.
- Storage and Temperature Control: The diagnostic kits required careful storage under specific temperature conditions, ranging from -20°C to -80°C, in addition to dry ice replenishment. Oximio ensured that the equipment was stored in the appropriate temperature-controlled environments within the bonded warehouse. To maintain the integrity of the kits, we partnered with a local carrier specialising in temperature-sensitive goods for regional distribution.
- Regional Distribution: Acting as the Exporter of Record (EoR), we facilitated the distribution of 12 outbound shipments of diagnostic kits to four research sites in Tanzania and Uganda. This included handling the IOR for the goods into the receiving countries and ensuring that each shipment was appropriately packaged for transport at the required temperatures, with dry ice replenishment when necessary.
- Rapid Delivery: Oximio’s efficient logistics network ensured that the diagnostic kits reached the study sites within 72 hours—substantially reducing the standard delivery time from 6 days (if shipped directly from the UK) to just 3 days.
- Swift Regulatory Compliance: The complex process of securing Importation of Record (IoR) permits for each country was conducted in 7 days, half of the usual 14+ days it would normally take. This expedited the entire logistics process, avoiding any unnecessary delays.
Results
The complete logistics process—from importation to final delivery—was executed smoothly. The shipments arrived at the designated study sites in Tanzania and Uganda on time and within the required temperature range, ensuring the diagnostic kits were ready for use in patient diagnostics without compromising their efficacy.
The research team was able to begin their diagnostic procedures as planned, avoiding any disruptions to their study timeline. Additionally, Oximio is now poised to handle site returns and perform reconciliation and destruction of expired or used kits in compliance with the study’s protocols.
Conclusion
Oximio successfully navigated the complexities of international shipping, temperature-sensitive transport, and regulatory compliance to deliver critical diagnostic kits for a TB research study in sub-Saharan Africa. The use of our customs bonded warehouse for storage and regional distribution not only streamlined the process but also saved valuable time, ensuring that the study’s diagnostic efforts were not hindered by logistics challenges.
This case highlights the importance of local knowledge, efficient customs handling, and temperature-controlled logistics in supporting global health initiatives in remote and challenging environments. Through careful planning and strategic partnerships, we were able to deliver results that directly supported the health and research outcomes of the TB study, ensuring timely diagnostics and contributing to the fight against tuberculosis in sub-Saharan Africa.
Oximio sub-Saharan Africa
For further information on our clinical trial supply chain solutions in sub-Saharan Africa, please contact us. We’d be delighted to discuss your project requirements.
